Search Videos and More
News
Venturing Into New Treatment Territory for Myelofibrosis with a Fox Chase Investigator-Initiated Study
The study is a phase one, single-site, dose-escalation study for patients with myeloproliferative neoplasms unresponsive to any JAK2 inhibitor. It combines two oral medications, Pacritinib and Talazoparib, and is for transplant-ineligible patients.
News
Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
News
Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships
A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
News
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be more effective alternative treatments.
News
A One-Stop Shop for Liver Cancer
Fox Chase Improves Treatment and Access to It
News
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
News
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?
News
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
News
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
News
The New Department of Urology at Fox Chase Cancer Center
Built on strength: world-class specialists, innovative researchers, and clinical leaders.
News
Transforming Cancer Care and Delivery
The new President and CEO of Fox Chase Cancer Center
News
A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?